News
Phathom Pharmaceuticals to Present at Upcoming Investor Conferences
FLORHAM PARK, N.J., May 28, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing…
Share
UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference
SAN FRANCISCO, May 28, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or…
Share
Geron Corporation Reports First Quarter 2020 Financial Results
MENLO PARK, Calif., May 28, 2020 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2020. The Company will host a…
Share
Illegal Online Pharmacies Exploit Vulnerable Consumers During the COVID-19 Pandemic
MOUNT PROSPECT, IL, May 26, 2020 (GLOBE NEWSWIRE) — The National Association of Boards of Pharmacy® (NABP®) released the May 2020 Rogue Rx Activity Report, Rogue Online Pharmacies in the…
Share
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
First participants enrolled in Phase 1 portion of clinical trial of NVX‑CoV2373Preliminary immunogenicity and safety results expected in July 2020Phase 2 portion to begin promptly following…
Share
CytoDyn to Hold Conference Call to Provide Updates on COVID-19 (Phase 2, 3 & eIND), Cancer (mTNBC, Phase 2 for 22 Solid Tumor Cancers), HIV (BLA, Monotherapy), NASH, GvHD and MS
VANCOUVER, Washington, May 22, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5…
Share
Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.
LOS ANGELES, May 22, 2020 (GLOBE NEWSWIRE) — Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger…
Share
Equillium to Present at Jefferies Virtual Healthcare Conference
LA JOLLA, Calif., May 21, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel…
Share
MacroGenics to Host Conference Call and Webcast to Review Preliminary Clinical Results for MGD013 and MGC018 to be Presented at ASCO
Rockville, MD, May 21, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal…
Share
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates
Geron plans to move forward with a Phase 3 clinical trial in refractory myelofibrosis (MF) with overall survival (OS) as a primary endpoint, which is expected to open for screening and…
Share